News
Layoffs
Digital HealthBetter Therapeutics Terminates Employees, Seeks Strategic AlternativesBetter Therapeutics Terminates Employees, Seeks Strategic Alternatives
The company obtained FDA approval for its AspyreRx PDT in 2023 but has since struggled to secure strong insurance coverage.
Sign up for the QMED & MD+DI Daily newsletter.